Market Cap : 39.85 B | Enterprise Value : 45.28 B | P/E (TTM) : 412.73 | P/B : 5.65 |
---|
BSX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BSX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
vs
industry |
vs
history |
||
---|---|---|---|
Cash-to-Debt | 0.03 |
98% of the 330 Companies in the Global Medical Devices industry. ( Industry Median: 2.32 vs. BSX: 0.03 ) Ranked among companies with meaningful Cash-to-Debt only. |
BSX'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.15 Max: 3.66 Current: 0.03 |
Equity-to-Asset | 0.37 |
86% of the 309 Companies in the Global Medical Devices industry. ( Industry Median: 0.63 vs. BSX: 0.37 ) Ranked among companies with meaningful Equity-to-Asset only. |
BSX'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21 Med: 0.5 Max: 0.83 Current: 0.37 |
Debt-to-Equity | 0.80 |
84% of the 220 Companies in the Global Medical Devices industry. ( Industry Median: 0.30 vs. BSX: 0.80 ) Ranked among companies with meaningful Debt-to-Equity only. |
BSX'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.52 Max: 2.91 Current: 0.8 |
Debt-to-EBITDA | 3.25 |
67% of the 158 Companies in the Global Medical Devices industry. ( Industry Median: 1.98 vs. BSX: 3.25 ) Ranked among companies with meaningful Debt-to-EBITDA only. |
BSX'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -88.33 Med: 3.64 Max: 37.25 Current: 3.25 |
Interest Coverage | 7.03 |
82% of the 212 Companies in the Global Medical Devices industry. ( Industry Median: 66.37 vs. BSX: 7.03 ) Ranked among companies with meaningful Interest Coverage only. |
BSX'
s Interest Coverage Range Over the Past 10 Years
Min: 2.47 Med: 3.29 Max: 7.03 Current: 7.03 |
Piotroski F-Score: 6 |
|
Altman Z-Score: 1.94 |
|
Beneish M-Score: -2.66 |
|
WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
vs
industry |
vs
history |
||
---|---|---|---|
Operating Margin % | 17.80 |
78% of the 312 Companies in the Global Medical Devices industry. ( Industry Median: 1.96 vs. BSX: 17.80 ) Ranked among companies with meaningful Operating Margin % only. |
BSX'
s Operating Margin % Range Over the Past 10 Years
Min: 11.6 Med: 12.9 Max: 17.81 Current: 17.8 |
Net Margin % | 1.15 |
50% of the 312 Companies in the Global Medical Devices industry. ( Industry Median: 1.40 vs. BSX: 1.15 ) Ranked among companies with meaningful Net Margin % only. |
BSX'
s Net Margin % Range Over the Past 10 Years
Min: -56.12 Med: -2.45 Max: 5.79 Current: 1.15 |
ROE % | 1.46 |
51% of the 304 Companies in the Global Medical Devices industry. ( Industry Median: 0.95 vs. BSX: 1.46 ) Ranked among companies with meaningful ROE % only. |
BSX'
s ROE % Range Over the Past 10 Years
Min: -44.65 Med: -2.79 Max: 5.32 Current: 1.46 |
ROA % | 0.56 |
52% of the 332 Companies in the Global Medical Devices industry. ( Industry Median: -0.26 vs. BSX: 0.56 ) Ranked among companies with meaningful ROA % only. |
BSX'
s ROA % Range Over the Past 10 Years
Min: -21.16 Med: -1.04 Max: 2.03 Current: 0.56 |
ROC (Joel Greenblatt) % | 69.87 |
90% of the 327 Companies in the Global Medical Devices industry. ( Industry Median: 3.87 vs. BSX: 69.87 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
BSX'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -144.7 Med: -14.88 Max: 69.87 Current: 69.87 |
3-Year Revenue Growth Rate | 5.20 |
52% of the 254 Companies in the Global Medical Devices industry. ( Industry Median: 4.30 vs. BSX: 5.20 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
BSX'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -10.5 Med: 4.9 Max: 29 Current: 5.2 |
3-Year EBITDA Growth Rate | 64.10 |
95% of the 232 Companies in the Global Medical Devices industry. ( Industry Median: 7.50 vs. BSX: 64.10 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
BSX'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0 Med: 13.15 Max: 83.1 Current: 64.1 |
Julian Robertson 900,000 sh (New) Caxton Associates 20,100 sh (New) Joel Greenblatt 1,664,082 sh (+1574.40%) David Tepper 3,340,000 sh (+507.27%) Jim Simons 5,726,705 sh (+118.13%) Diamond Hill Capital 3,361,258 sh (+0.29%) | John Paulson Sold Out Steven Cohen Sold Out Ray Dalio Sold Out Pioneer Investments 1,938,677 sh (-0.12%) PRIMECAP Management 41,755,967 sh (-0.39%) Vanguard Health Care Fund 42,272,393 sh (-3.65%) Mario Gabelli 625,559 sh (-4.22%) Dodge & Cox 328,655 sh (-11.57%) Michael Price 500,000 sh (-28.57%) |
Steven Cohen 1,047,500 sh (New) Eaton Vance Worldwide Health Sciences Fund 936,126 sh (New) Julian Robertson 1,069,500 sh (+18.83%) Pioneer Investments 1,974,820 sh (+1.86%) PRIMECAP Management 42,369,167 sh (+1.47%) | Caxton Associates Sold Out Dodge & Cox 324,255 sh (-1.34%) Vanguard Health Care Fund 41,119,293 sh (-2.73%) Jim Simons 5,305,605 sh (-7.35%) Diamond Hill Capital 3,013,614 sh (-10.34%) Mario Gabelli 551,059 sh (-11.91%) David Tepper 2,264,900 sh (-32.19%) Michael Price 295,000 sh (-41.00%) Joel Greenblatt 24,597 sh (-98.52%) |
David Tepper 3,752,866 sh (+65.70%) Joel Greenblatt 28,643 sh (+16.45%) | Julian Robertson 1,069,500 sh (unchged) Eaton Vance Worldwide Health Sciences Fund 936,126 sh (unchged) | Diamond Hill Capital 3,009,893 sh (-0.12%) PRIMECAP Management 42,168,267 sh (-0.47%) Vanguard Health Care Fund 39,692,793 sh (-3.47%) Michael Price 284,200 sh (-3.66%) Mario Gabelli 527,859 sh (-4.21%) Pioneer Investments 1,864,993 sh (-5.56%) Dodge & Cox 302,355 sh (-6.75%) Jim Simons 2,012,405 sh (-62.07%) Steven Cohen 125,500 sh (-88.02%) |
John Hussman 50,000 sh (New) David Carlson 750,000 sh (New) Ray Dalio 176,079 sh (New) Caxton Associates 44,975 sh (New) Paul Tudor Jones 195,667 sh (New) Joel Greenblatt 503,669 sh (+1658.44%) David Tepper 4,782,683 sh (+27.44%) PRIMECAP Management 43,877,562 sh (+4.05%) Vanguard Health Care Fund 40,024,604 sh (+0.84%) Diamond Hill Capital 3,024,204 sh (+0.48%) | Michael Price 284,200 sh (unchged) | Julian Robertson Sold Out Steven Cohen Sold Out Mario Gabelli 452,909 sh (-14.20%) Dodge & Cox 253,355 sh (-16.21%) Jim Simons 1,146,305 sh (-43.04%) Pioneer Investments 854,578 sh (-54.18%) Eaton Vance Worldwide Health Sciences Fund 816,790 sh (-12.75%) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
---|---|---|---|---|---|---|---|---|
Vanguard Health Care Fund | 2017-12-31 | Add 0.84% | 0.02% | $24.79 - $29.8 | $ 28.89 | 5% | 40,024,604 | ![]() |
David Tepper | 2017-12-31 | Add 27.44% | 0.24% | $24.79 - $29.8 | $ 28.89 | 5% | 4,782,683 | ![]() |
Joel Greenblatt | 2017-12-31 | Add 1658.44% | 0.17% | $24.79 - $29.8 | $ 28.89 | 5% | 503,669 | ![]() |
Mario Gabelli | 2017-12-31 | Reduce -14.20% | 0.01% | $24.79 - $29.8 | $ 28.89 | 5% | 452,909 | ![]() |
Dodge & Cox | 2017-12-31 | Reduce -16.21% | $24.79 - $29.8 | $ 28.89 | 5% | 253,355 | ![]() | |
Julian Robertson | 2017-12-31 | Sold Out | 5.64% | $24.79 - $29.8 | $ 28.89 | 5% | 0 | ![]() |
Vanguard Health Care Fund | 2017-09-30 | Reduce -3.47% | 0.08% | $26.26 - $29.17 | $ 28.89 | 5% | 39,692,793 | ![]() |
David Tepper | 2017-09-30 | Add 65.70% | 0.61% | $26.26 - $29.17 | $ 28.89 | 5% | 3,752,866 | ![]() |
Mario Gabelli | 2017-09-30 | Reduce -4.21% | $26.26 - $29.17 | $ 28.89 | 5% | 527,859 | ![]() | |
Dodge & Cox | 2017-09-30 | Reduce -6.75% | $26.26 - $29.17 | $ 28.89 | 5% | 302,355 | ![]() | |
Michael Price | 2017-09-30 | Reduce -3.66% | 0.04% | $26.26 - $29.17 | $ 28.89 | 5% | 284,200 | ![]() |
Joel Greenblatt | 2017-09-30 | Add 16.45% | $26.26 - $29.17 | $ 28.89 | 5% | 28,643 | ![]() | |
Vanguard Health Care Fund | 2017-06-30 | Reduce -2.73% | 0.06% | $24.42 - $28.25 | $ 28.89 | 9% | 41,119,293 | ![]() |
David Tepper | 2017-06-30 | Reduce -32.19% | 0.44% | $24.42 - $28.25 | $ 28.89 | 9% | 2,264,900 | ![]() |
Julian Robertson | 2017-06-30 | Add 18.83% | 0.92% | $24.42 - $28.25 | $ 28.89 | 9% | 1,069,500 | ![]() |
Mario Gabelli | 2017-06-30 | Reduce -11.91% | 0.01% | $24.42 - $28.25 | $ 28.89 | 9% | 551,059 | ![]() |
Dodge & Cox | 2017-06-30 | Reduce -1.34% | $24.42 - $28.25 | $ 28.89 | 9% | 324,255 | ![]() | |
Michael Price | 2017-06-30 | Reduce -41.00% | 0.63% | $24.42 - $28.25 | $ 28.89 | 9% | 295,000 | ![]() |
Joel Greenblatt | 2017-06-30 | Reduce -98.52% | 0.52% | $24.42 - $28.25 | $ 28.89 | 9% | 24,597 | ![]() |
Industry: | Medical Devices » Medical Devices NAICS: 339112 SIC: 3841 | |
---|---|---|
Compare: | NYSE:EW, NAS:ISRG, NYSE:ZBH, NAS:ALGN, LSE:SN., NYSE:SYK, NAS:ABMD, NYSE:TFX, NYSE:VAR, XSWX:SOON, OCSE:WDH, SZSE:300003, ASX:COH, XPAR:DIM, NZSE:FPH, LSE:CTEC, OCSE:GN, NYSE:GMED, OCSE:AMBU B, NAS:MASI » details | |
Traded in other countries: | BSX.Germany, | |
Headquarter Location: | USA |
vs
industry |
vs
history |
||
---|---|---|---|
PE Ratio | 412.73 |
98% of the 180 Companies in the Global Medical Devices industry. ( Industry Median: 30.17 vs. BSX: 412.73 ) Ranked among companies with meaningful PE Ratio only. |
BSX'
s PE Ratio Range Over the Past 10 Years
Min: 13.87 Med: 46.57 Max: 414.29 Current: 412.73 |
Forward PE Ratio | 21.05 |
71% of the 52 Companies in the Global Medical Devices industry. ( Industry Median: 25.06 vs. BSX: 21.05 ) Ranked among companies with meaningful Forward PE Ratio only. |
N/A |
PE Ratio without NRI | 412.73 |
98% of the 179 Companies in the Global Medical Devices industry. ( Industry Median: 30.17 vs. BSX: 412.73 ) Ranked among companies with meaningful PE Ratio without NRI only. |
BSX'
s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.87 Med: 46.57 Max: 414.29 Current: 412.73 |
PB Ratio | 5.65 |
70% of the 310 Companies in the Global Medical Devices industry. ( Industry Median: 3.06 vs. BSX: 5.65 ) Ranked among companies with meaningful PB Ratio only. |
BSX'
s PB Ratio Range Over the Past 10 Years
Min: 0.59 Med: 1.45 Max: 5.68 Current: 5.65 |
PS Ratio | 4.43 |
59% of the 294 Companies in the Global Medical Devices industry. ( Industry Median: 3.15 vs. BSX: 4.43 ) Ranked among companies with meaningful PS Ratio only. |
BSX'
s PS Ratio Range Over the Past 10 Years
Min: 1.02 Med: 2.22 Max: 4.65 Current: 4.43 |
Price-to-Free-Cash-Flow | 36.44 |
61% of the 107 Companies in the Global Medical Devices industry. ( Industry Median: 26.44 vs. BSX: 36.44 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
BSX'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.21 Med: 22.72 Max: 220 Current: 36.44 |
Price-to-Operating-Cash-Flow | 28.21 |
66% of the 127 Companies in the Global Medical Devices industry. ( Industry Median: 20.01 vs. BSX: 28.21 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
BSX'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.75 Med: 16.73 Max: 62.72 Current: 28.21 |
EV-to-EBIT | 38.99 |
73% of the 174 Companies in the Global Medical Devices industry. ( Industry Median: 24.76 vs. BSX: 38.99 ) Ranked among companies with meaningful EV-to-EBIT only. |
BSX'
s EV-to-EBIT Range Over the Past 10 Years
Min: -5167.6 Med: -3.2 Max: 317.6 Current: 38.99 |
EV-to-EBITDA | 26.24 |
69% of the 188 Companies in the Global Medical Devices industry. ( Industry Median: 18.14 vs. BSX: 26.24 ) Ranked among companies with meaningful EV-to-EBITDA only. |
BSX'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -680.1 Med: 11.3 Max: 242.5 Current: 26.24 |
EV-to-Revenue | 5.00 |
62% of the 309 Companies in the Global Medical Devices industry. ( Industry Median: 3.73 vs. BSX: 5.00 ) Ranked among companies with meaningful EV-to-Revenue only. |
BSX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1 Med: 2.8 Max: 5.3 Current: 5 |
Current Ratio | 0.68 |
94% of the 324 Companies in the Global Medical Devices industry. ( Industry Median: 2.71 vs. BSX: 0.68 ) Ranked among companies with meaningful Current Ratio only. |
BSX'
s Current Ratio Range Over the Past 10 Years
Min: 0.68 Med: 1.52 Max: 5.55 Current: 0.68 |
Quick Ratio | 0.49 |
93% of the 324 Companies in the Global Medical Devices industry. ( Industry Median: 2.03 vs. BSX: 0.49 ) Ranked among companies with meaningful Quick Ratio only. |
BSX'
s Quick Ratio Range Over the Past 10 Years
Min: 0.49 Med: 1.16 Max: 4.6 Current: 0.49 |
Days Inventory | 140.02 |
50% of the 294 Companies in the Global Medical Devices industry. ( Industry Median: 143.61 vs. BSX: 140.02 ) Ranked among companies with meaningful Days Inventory only. |
BSX'
s Days Inventory Range Over the Past 10 Years
Min: 116.64 Med: 140.22 Max: 159.64 Current: 140.02 |
Days Sales Outstanding | 62.45 |
58% of the 276 Companies in the Global Medical Devices industry. ( Industry Median: 69.21 vs. BSX: 62.45 ) Ranked among companies with meaningful Days Sales Outstanding only. |
BSX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.51 Med: 61.98 Max: 66.79 Current: 62.45 |
Days Payable | 72.70 |
60% of the 261 Companies in the Global Medical Devices industry. ( Industry Median: 58.34 vs. BSX: 72.70 ) Ranked among companies with meaningful Days Payable only. |
BSX'
s Days Payable Range Over the Past 10 Years
Min: 25.84 Med: 35.69 Max: 72.7 Current: 72.7 |
vs
industry |
vs
history |
||
---|---|---|---|
3-Year Average Share Buyback Ratio | -1.10 |
73% of the 244 Companies in the Global Medical Devices industry. ( Industry Median: -5.70 vs. BSX: -1.10 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
BSX'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -25.9 Med: -1 Max: 4.6 Current: -1.1 |
vs
industry |
vs
history |
||
---|---|---|---|
Price-to-Intrinsic-Value-Projected-FCF | 2.88 | ||
Price-to-Median-PS-Value | 2.00 |
86% of the 237 Companies in the Global Medical Devices industry. ( Industry Median: 1.02 vs. BSX: 2.00 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
BSX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.48 Med: 1.49 Max: 4.02 Current: 2 |
Earnings Yield (Greenblatt) % | 2.56 |
62% of the 332 Companies in the Global Medical Devices industry. ( Industry Median: 0.74 vs. BSX: 2.56 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
BSX'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -34.3 Med: -0.3 Max: 9.1 Current: 2.56 |
Forward Rate of Return (Yacktman) % | -15.10 |
96% of the 125 Companies in the Global Medical Devices industry. ( Industry Median: 6.60 vs. BSX: -15.10 ) Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only. |
BSX'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -15.1 Med: 6.5 Max: 17 Current: -15.1 |
Revenue (TTM) (Mil) $ | 9,047.00 |
---|---|
EPS (TTM) $ | 0.07 |
Beta | 0.96 |
Volatility | 19.81% |
52-Week Range $ | 24.31 - 29.93 |
Shares Outstanding (Mil) | 1,379.50 |
Dec18 | Dec19 | Dec20 | |
---|---|---|---|
Revenue (Mil $) | 9,523 | 10,200 | 10,894 |
EBIT (Mil $) | 1,832 | 2,141 | |
EBITDA (Mil $) | 2,747 | 3,244 | |
EPS ($) | 1.38 | 1.55 | 1.75 |
EPS without NRI ($) | 1.38 | 1.55 | 1.75 |
EPS Growth Rate (Future 3Y To 5Y Estimate) | 13.31% | ||
Dividends per Share ($) |
|
Can MedSurg Business Aid Boston Scientific (BSX) Q1 Earnings? Apr 17 2018 - ZACKS |
GF Chat